Tag Archives: biopharma

Protect Yourself from a Hack Attack

Protect Yourself from a Hack Attack

Gone are the days when biotech’s biggest activist threats came from lab break-ins and physical attacks. Today almost anyone wishing to damage companies can steal, disrupt or harm employees 24-hours a day and from anywhere in the world. Hackers are anything BUT anonymous Last year the notorious group Anonymous took credit for hacking Monsanto Co. due to the company’s alleged “crimes against humanity.” It was the third hack Anonymous aimed against the the company, and Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Landing the Big One: How to Score a Partnering Meeting with Big Biopharma

Partnering

You’ve registered for the BIO Business Forum and received your log-in credentials. You’ve updated your drug assets and published your company’s profile. You peruse the list of other participating companies, looking for potential partners to message. Then, you see them. The big fish in the biopharma partnering pond. You decide to send them a meeting request and wonder, “How can I increase my chances of actually meeting with them face-to-face in Chicago?” To answer this Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

It Takes a Village: The New Pharma-VC Model for Biotech Investing

bif-hall

High-profile funding collaborations between pharmaceutical companies and traditional venture capital funds have made headlines in recent months, pooling resources and expertise in an attempt to source and develop the most successful drugs. BIO Executive Vice President Alan Eisenberg moderated It Takes a Village: The New Pharma-VC Model for Biotech Investing, a panel discussion about these new funding models, during the opening plenary session at the 2012 BIO Investor Forum. In the past, venture capital could Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

What Will It Take for the U.S. to Maintain Leadership in the Biopharma Industry?

deborah

The biopharmaceutical industry is an important contributor to U.S. economic growth and sustainability, with more than 650,000 direct jobs (supporting a total of nearly 4 million jobs) and an economic output that totals more than $900 billion.[i] This significant economic impact is due to the high value-added nature of the sector, its extensive supply chain relationships, and high-wage jobs. As a result, gains and losses in the biopharmaceutical sector cascade across many important economic sectors Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , ,

#BIF2012 Company Snapshot: Profil Institute for Translational Medicine

profil_trans_med

For the next Company Snapshot for the BIO Investor Forum, we’ve spoken with one of the presenting companies at the event, Profil Institute for Translational Medicine, Inc. To find out more about this organization and what they’re doing for biotech, please read below! You’ll be able to see their presentation onsite, Wednesday 10/10 at 9:30am in the Presidio Room.   Company Snapshot What is your company’s lead product or technology? Based on collaborations with biopharma, Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , ,